middle.news
FDA Closes Manufacturing Module in Imricor’s PMA Submission
8:21am on Thursday 3rd of September, 2026 AEST
•
Healthcare
Read Story
FDA Closes Manufacturing Module in Imricor’s PMA Submission
8:21am on Thursday 3rd of September, 2026 AEST
Key Points
FDA accepts and closes manufacturing module
Module covers seven devices including Vision-MR and RF-5000
Pre-approval inspection of manufacturing sites pending
Milestone advances modular PMA review process
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imricor Medical Systems (ASX:IMR)
OPEN ARTICLE